SINGAPORE (April 6): OCBC Investment Research is advising shareholders of Biosensors International Group to accept the cash offer of 84 cents each for a merger with China-based CB Medical Holdings, rather than take up the share offer in the group entity.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply